Lmr Partners LLP Bicycle Therapeutics PLC Transaction History

Lmr Partners LLP

  • $10.5 Billion
  • Q2 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$12.95 - $46.99 $521,664 - $1.89 Million
-40,283 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$40.12 - $59.5 $11,353 - $16,838
283 Added 0.71%
40,283 $1.77 Million
Q4 2021

Feb 14, 2022
BUY
$41.7 - $61.14 $1.67 Million - $2.45 Million
40,000 New
40,000 $2.44 Million

Others Institutions Holding BCYC

# of Institutions
117
Shares Held
42M
Call Options Held
111K
Put Options Held
16.6K
View Full List

About BICYCLE THERAPEUTICS plc

BCYC Quotes by TradingView
  • Ticker BCYC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,676,100
  • Market Cap $260M
  • Description
  • Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...
More about BCYC
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email